Wellington Management Group LLP recently revealed that they own 3.6% of EndoChoice Holdings Inc. (NYSE:GI) in a Schedule 13G/A disclosure that was filed with the SEC on Tuesday, October 11th. The investor owns 923,884 shares of the stock worth approximately $7,372,594. The reporting parties listed on the disclosure included Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP. The filing is available through EDGAR at this link.
Other hedge funds also recently added to or reduced their stakes in the company. Paloma Partners Management Co acquired a new position in shares of EndoChoice Holdings during the second quarter valued at $161,000. Emerald Acquisition Ltd. acquired a new position in shares of EndoChoice Holdings during the second quarter valued at $215,000. Spark Investment Management LLC acquired a new position in shares of EndoChoice Holdings during the second quarter valued at $318,000. Bridgeway Capital Management Inc. acquired a new position in shares of EndoChoice Holdings during the second quarter valued at $368,000. Finally, State Street Corp raised its position in shares of EndoChoice Holdings by 46.7% in the first quarter. State Street Corp now owns 76,915 shares of the company’s stock valued at $402,000 after buying an additional 24,500 shares in the last quarter. 38.67% of the stock is currently owned by institutional investors and hedge funds.
EndoChoice Holdings Inc. (NYSE:GI) traded down 0.13% during midday trading on Tuesday, reaching $7.97. 26,243 shares of the company’s stock traded hands. The stock’s 50 day moving average price is $5.25 and its 200 day moving average price is $4.88. EndoChoice Holdings Inc. has a 1-year low of $3.64 and a 1-year high of $12.06. The firm’s market cap is $207.59 million.
EndoChoice Holdings (NYSE:GI) last issued its earnings results on Wednesday, August 3rd. The company reported ($0.99) EPS for the quarter, missing the consensus estimate of ($0.52) by $0.47. The firm earned $19.30 million during the quarter, compared to analyst estimates of $20.67 million. EndoChoice Holdings had a negative net margin of 88.94% and a negative return on equity of 62.04%. EndoChoice Holdings’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($1.01) earnings per share. Equities research analysts anticipate that EndoChoice Holdings Inc. will post ($2.53) EPS for the current year.
GI has been the topic of several analyst reports. Zacks Investment Research upgraded shares of EndoChoice Holdings from a “hold” rating to a “buy” rating and set a $5.25 price objective on the stock in a report on Tuesday, July 5th. Stifel Nicolaus cut their price objective on shares of EndoChoice Holdings from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Thursday, August 4th. William Blair restated a “market perform” rating on shares of EndoChoice Holdings in a report on Friday, September 30th. Finally, JPMorgan Chase & Co. lowered shares of EndoChoice Holdings from an “overweight” rating to a “neutral” rating in a report on Thursday, August 4th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $7.42.
About EndoChoice Holdings
EndoChoice Holdings, Inc is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.
Want to see what other hedge funds are holding GI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for EndoChoice Holdings Inc. (NYSE:GI).
Receive News & Ratings for EndoChoice Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EndoChoice Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.